Liver Cancer
Latest News
Advertisement
Advertisement
In this segment, David Liu, shares a case study of a 33-year-old woman with stage 4 colorectal cancer that had metastasized to the liver.
An analysis of patients with advanced hepatocellular carcinoma and elevated AFP who received second-line Cyramza showed improved survival, according to data from the phase 3 REACH study.
Researchers need to learn more about the biology of liver cancer to develop better treatments.
Refined treatments and targeted drugs signal slow yet significant progress for liver cancer.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5